|
2024
|
Invention
|
Modified release composition. A modified release composition comprising dydrogesterone or a pharm... |
|
2019
|
Invention
|
Pharmaceutical composition containing a peptide. The present invention relates to a stable pharma... |
|
2018
|
Invention
|
Enzyme compositions with reduced viral and microbial contamination. The present invention pertain... |
|
2015
|
Invention
|
Processes for producing compositions with improved safety profile comprising pancreatin and compo... |
|
2011
|
Invention
|
Pharmaceutical compositions comprising a selective i1 imidazoline receptor agonist and an angiote... |
|
2008
|
Invention
|
Novel process for separating and determining the viral load in a pancreatin sample. Process... |
|
2007
|
Invention
|
Process for separating and determining the viral load in a pancreatin sample. Processes for separ... |
|
2006
|
Invention
|
Controlled release pharmaceutical compositions for acid labile drugs. An enteric-coated ora... |
|
|
Invention
|
Pancreatin micropellet cores suitable for enteric coating. Described herein are a process f... |
|
|
Invention
|
Processes for the manufacture of sterilized pancreatin powder. Disclosed is a process for t... |
|
2005
|
Invention
|
Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary ... |
|
|
Invention
|
Essential fatty acids in the prevention and/or treatment of depression in patients with coronary ... |
|
|
Invention
|
Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, cont... |
|
2004
|
Invention
|
Method for the treatment of diseases requiring inhibition or a reduction in the activity of ph va... |
|
|
Invention
|
Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angioten... |
|
|
Invention
|
Analytical method for pancreatin and comparable compositions. The present invention concern... |
|
2003
|
Invention
|
Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and methods... |
|
2001
|
Invention
|
Use of moxonidine for postmyocardial infarction treatment. A method of treating myocardial damage... |
|
2000
|
Invention
|
Method of treating or inhibiting functional disturbances or illnesses of the lower intestinal tra... |
|
|
Invention
|
Medicinal product for the treatment of diabetes. The invention relates to the use of physio... |
|
|
Invention
|
Use of moxonidine for postmyocardial infarction treatment. The use of moxonidine and its p... |
|
1998
|
Invention
|
Nephroprotective pharmaceutical composition and use thereof. The use of sub-antihypertensive dose... |
|
1997
|
Invention
|
Method of inhibiting hyperglycemia and pharmaceutical composition for use therein. A method of us... |
|
|
Invention
|
Method of stabilizing pharmaceutical preparations comprising digestive enzyme mixtures. The use o... |
|
1995
|
Invention
|
Anti-hyperglycemia pharmaceutical composition. A method of using moxonidine or a physiologically ... |
|
1993
|
Invention
|
Pancreatin micropellets. Pancreatin-containing micropellet cores which can be coated with a gastr... |
|
1992
|
Invention
|
Crystalline fumaric acid salts of 9,9-alkylene-3,7-diazabicyclononane compounds and pharmaceutica... |
